- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x W1G: 2-PHENOXY-5-(2-PROPENYL)PHENOL(Non-covalent)
W1G.2: 13 residues within 4Å:- Chain A: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230
- Ligands: NAP.1
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:A.121, A:L.128, A:Y.173, A:Y.173, A:Y.173, A:Y.183, A:Y.183, A:A.224, A:V.227, A:V.227
- Hydrogen bonds: A:Y.183
- pi-Stacking: A:Y.173
W1G.6: 13 residues within 4Å:- Chain B: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230
- Ligands: NAP.5
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:A.121, B:L.128, B:Y.173, B:Y.173, B:Y.173, B:Y.183, B:Y.183, B:A.224, B:V.227, B:V.227, B:F.230
W1G.9: 13 residues within 4Å:- Chain C: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230
- Ligands: NAP.8
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:L.128, C:Y.173, C:Y.173, C:Y.173, C:Y.183, C:Y.183, C:A.224, C:V.227, C:V.227
- Hydrogen bonds: C:Y.183
W1G.12: 14 residues within 4Å:- Chain D: A.121, F.122, A.123, L.128, Y.173, Y.183, M.186, K.190, S.223, A.224, V.227, F.230, I.233
- Ligands: NAP.11
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:A.121, D:L.128, D:Y.173, D:Y.173, D:Y.173, D:Y.183, D:Y.183, D:A.224, D:V.227, D:V.227, D:F.230, D:I.233
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
GLU.3: 10 residues within 4Å:- Chain A: K.33, Y.35, D.114, G.166, S.167, N.208, R.210, L.260, S.261, S.265
8 PLIP interactions:6 interactions with chain A, 2 Ligand-Ligand interactions- Hydrogen bonds: A:Y.35, A:D.114
- Water bridges: A:K.33, A:D.262, E.3, E.3
- Salt bridges: A:K.33, A:R.210
GLU.4: 8 residues within 4Å:- Chain A: R.129, A.224, K.225, V.227, G.228, G.229, F.230, N.231
5 PLIP interactions:5 interactions with chain A,- Hydrogen bonds: A:K.225, A:G.229, A:F.230, A:N.231
- Salt bridges: A:R.129
GLU.7: 6 residues within 4Å:- Chain B: R.129, A.224, K.225, V.227, G.229, F.230
5 PLIP interactions:5 interactions with chain B,- Hydrogen bonds: B:K.225, B:G.229, B:F.230
- Water bridges: B:N.231
- Salt bridges: B:R.129
GLU.10: 6 residues within 4Å:- Chain C: R.129, V.227, G.228, G.229, F.230, N.231
8 PLIP interactions:4 interactions with chain C, 4 Ligand-Ligand interactions- Hydrogen bonds: C:G.229, C:F.230, C:N.231, E.10, E.10, E.10, E.10
- Salt bridges: C:R.129
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, A. et al., Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the S. Aureus Fabi Enzyme-Product Complex. Biochemistry (2013)
- Release Date
- 2013-06-05
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x W1G: 2-PHENOXY-5-(2-PROPENYL)PHENOL(Non-covalent)
- 4 x GLU: GLUTAMIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chang, A. et al., Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the S. Aureus Fabi Enzyme-Product Complex. Biochemistry (2013)
- Release Date
- 2013-06-05
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D